Paper Details

  1. Home
  2. Paper Details

Critical appraisal of selegiline transdermal system for major depressive disorder.

Author: CristanchoMario A, ThaseMichael E

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

The selegiline transdermal delivery system, the first antidepressant patch, has a safe profile and may be a viable option for difficult-to-treat conditions.
Paper Details　
Original Abstract of the Article :
Although safer and easier to use antidepressants (ie.,SSRIs/SNRIs) have largely displaced MAOIs, these medications still have a role in difficult to treat conditions. Efforts to improve MAOIs benefit-risk profile resulted on the reversible MAOI and in the first antidepressant patch (selegiline trans...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1517/17425247.2016.1140145

データ提供：米国国立医学図書館（NLM）

Selegiline Transdermal System: A New Oasis in the Desert of Depression

The search for safe and effective treatments for depression continues to be a vital pursuit in mental health research. This research delves into the safety and efficacy of the selegiline transdermal system (STS), a novel approach to delivering the MAOI antidepressant selegiline.

A New Frontier in Antidepressant Therapy

This study explores the benefits of the STS, offering a promising alternative to traditional MAOIs, which often come with a higher risk of adverse effects. The authors discuss the potential benefits of this transdermal delivery system, highlighting its safety profile and efficacy in treating depression.

A Journey Towards a Brighter Horizon

This research offers hope for individuals seeking relief from depression, suggesting a potentially safer and more convenient treatment option with the STS. The transdermal delivery system may provide a more comfortable and effective way to manage depression, allowing patients to navigate their journey towards a brighter horizon.

Dr. Camel's Conclusion

The selegiline transdermal system, like a refreshing oasis in the desert of depression, offers a promising new frontier in antidepressant therapy. This research sheds light on the potential benefits of this novel delivery system, emphasizing its safety and efficacy in treating depression.

Date :
  1. Date Completed 2016-09-27
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

26837935

DOI: Digital Object Identifier

10.1517/17425247.2016.1140145

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.